Next Quarterly Earnings
Thursday, August 6, 2026
CW 32
Pre-Market
In 32 days
Xeris Biopharma Holdings
Xeris Biopharma Holdings is a US-based biopharmaceutical company that develops and markets innovative therapeutic solutions for rare endocrine diseases and diabetes. The company focuses on providing ready-to-use injectable solutions to improve patient care and simplify therapy. Their medications target unmet medical needs.
All Dates
Earnings history data not available
Company Information
Name
Xeris Biopharma Holdings
Country
🇺🇸
More Financial Information